Early safety indicators of COVID-19 convalescent plasma in 5000 patients

Michael J. Joyner(WinnMed), Arturo Casadevall(Johns Hopkins University), Chad C. Wiggins(Johns Hopkins University), Andrew J. Clayburn(Johns Hopkins University), Elizabeth R. Lesser(Mayo Clinic), Camille M. van Buskirk(Johns Hopkins University), Stephen A. Klassen(Brock University), Allan M. Klompas(Mayo Clinic in Florida), Rickey E. Carter(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), Emily R. Whelan(Mayo Clinic in Florida), John R.A. Shepherd(Johns Hopkins University), Kylie J. Andersen(Johns Hopkins University), James R. Stubbs(Johns Hopkins University), Jeffrey L. Winters(Mayo Clinic), Janis E. Blair(Mayo Clinic Hospital), Philippe R. Bauer(Mayo Clinic in Florida), Jonathon W. Senefeld(University of Illinois Urbana-Champaign), Robert F. Rea(Harvard–MIT Division of Health Sciences and Technology), Vitaly Herasevich(Mayo Clinic in Florida), Katie L. Kunze(Mayo Clinic in Arizona), R. Scott Wright(Pacific Heart Institute), Patrick W. Johnson(Mayo Clinic in Florida), Matthew R. Spiegel(Mayo Clinic in Florida), Kathryn F. Larson(Johns Hopkins University), Sarah E. Baker(Johns Hopkins University), Juan G. Ripoll(Johns Hopkins University), Nicole Verdun(Center for Biologics Evaluation and Research), Riley J. Regimbal(Johns Hopkins University), Nigel Paneth, DeLisa Fairweather(Mayo Clinic), David O. Hodge(WinnMed), Matthew Buras, Peter Marks(Center for Biologics Evaluation and Research), Joshua J. Dennis(Johns Hopkins University), Matthew N.P. Vogt(Johns Hopkins University)
Journal of Clinical Investigation
June 11, 2020
Cited by 485


Related Papers